POR in CD is biologically interesting. Endo and surgical POR Benjamin Cohen MD MAS Ben Click study CGH

▶️biologics ⬇️🔦recurrence (across risk)

▶️biologics did not ⬇️✂️in low risk for POR

🟢total n good, so why? are we bad at risk stratifying POR?

cghjournal.org/article/S1542-…

A tour de force of all things postop Crohn’s by Salam Bachour

CD POR despite postop biologic prophylaxis?

Our study showed switching to a new biologic class leads to ⬇️ POR at next scope (aOR 0.26) and ⬆️ endoscopic healing (aOR 3.4) compared to therapy optimization! journals.lww.com/jcge/abstract/…

Ben Click Benjamin Cohen MD MAS Edward Barnes MD MPH Miguel Regueiro

Don't miss Frank I Scott, MD MSCE speak on 'AI in IBD' to learn better #patientcare strategies! Join us at #RMIBD2024 March 15-17. Register today at rockymountainibd.com #IBD #Gastroenterology #MedEd @Waseem_Ahmed Ben Click David T. Rubin, MD Millie Long Michael Chiorean

Join us in beautiful Sun Valley, Idaho March 15-17 for #RMIBD2024 with fantastic talks from Millie Long Michael Chiorean Frank I Scott, MD MSCE Ben Click & more. Now offering travel grants for interested GI fellows too! Register at: rockymountainibd.com

‼️ study: Proactive analgesic protocol reduces inpatient opiate use with similar pain control in IBD. Important steps to reducing opiate exposure, associated with many poor outcomes. Anyone else doing this? Waseem Ahmed Frank I Scott, MD MSCE Joseph Sleiman, MD
nature.com/articles/s4159…

Like skiing? Like IBD? Need CME?
Check out the🌟studded lineup for RMIBD 2024!
➡️Optimizing 💉, Preventing Complications Millie Long
➡️New Treatments, Intestinal Ultrasound Michael Chiorean
➡️Perianal CD Waseem Ahmed
➡️AI in IBD Frank I Scott, MD MSCE
And more!
rockymountainibd.com

Ecstatic “Matches” what we feel right now CU Department of Medicine CU Anschutz Medical Campus GI and Hepatology Prashanth Francis, MD PhD This crew is top-notch! 🔥🔥🌟🌟
Welcome to the CU GI Fam!

With new approval in US, important considerations for SC switching from IV IFX in #REMSWITCH . Maybe straight to 240 mg qow in the 10 mg/kg q4w crowd? ⁦Shrinivas Bishu⁩ ⁦David Fudman, MD⁩ ⁦Aline Charabaty, MD, FACG, AGAF⁩ cghjournal.org/article/S1542-…

Potential game changer for those pesky small bowel AVMs and octreotide access difficulty nejm.org/doi/full/10.10…

#3 Retrospective study comparing UST to ADAL in post operative recurrence in CD. No difference in rates of post-op recurrence. In high risk patients is any biologic ok? Miguel Regueiro Matthieu Allez

#2 SPICY RCT (got to love the name) Extensive mesenteric resection (compared to current mesenteric sparing surgery) for ileocecal CD did not improve rates of post-op recurrence. The end of further studies looking at the mesentery in POR CD? Miguel Regueiro Matthieu Allez

Spotted at Granville Island Public Market. The marketing at #acg2023 has reached a new level.

SQ VDZ approved for UC by U.S. FDA Sept 27, 2023

Data in Gastroenterology (VISIBLE1 Trial) 👇🏾

1. IV wk 0, 2 --> SQ EOW maintenance

2. IV maint. = SQ maint. for endpoints.

3. Check the diagram below the title. Done.

gastrojournal.org/article/S0016-…

📢 SEQUENCE: another head-to-head study in IBD ft. risankizumab vs ustekinumab in Crohn's disease and prior anti-TNF exposure. RISA was non-inferior for clinical remission and superior for endoscopic remission when compared to UST. Details ⬇️

prnewswire.com/news-releases/…

🖨️📢 #Vedolizumab is comparable to #antiTNF tx in mgmt of steroid refractory #microscopic_colitis

Nabil El Hage Chehade Darrell Pardi Francis (Frank) Farraye, MD, MSc Sara Ghoneim, MD, MS Joao C Guimaraes

Efficacy and Safety of Vedolizumab and Tumor Necrosis... : Journal of Clinical Gastroenterology journals.lww.com/jcge/abstract/…

What a pleasure commenting on this 👌work using multicenter cohort

➡️rates of postop monitoring after resections for Crohn’s improving but still need to 📈
➡️calprotectin underused and not picking up speed
➡️identifying risk factors to lack of monitoring 🔑

👏the research team

Take a look at our recent study in Digestive Diseases and Sciences from Terry Li, MD NYU Langone Health and Cleveland Clinic on real-life monitoring of postoperative #Crohnsdisease !
Ben Click Benjamin Cohen MD MAS Salam Bachour #IBD

link.springer.com/article/10.100…

And commentary by David Fudman, MD rdcu.be/diQke